Mackenzie Financial’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.1K | Hold |
17,487
| – | – | ﹤0.01% | 1662 |
|
|
2025
Q1 | $58.2K | Hold |
17,487
| – | – | ﹤0.01% | 1617 |
|
|
2024
Q4 | $129K | Buy |
17,487
+1,540
| +10% | +$11.4K | ﹤0.01% | 1613 |
|
|
2024
Q3 | $150K | Buy |
15,947
+1,784
| +13% | +$16.8K | ﹤0.01% | 1435 |
|
|
2024
Q2 | $114K | Hold |
14,163
| – | – | ﹤0.01% | 1418 |
|
|
2024
Q1 | $210K | Buy |
+14,163
| New | +$210K | ﹤0.01% | 1324 |
|
|
2023
Q2 | – | Sell |
-60,571
| Closed | -$370K | – | 1572 |
|
|
2023
Q1 | $370K | Buy |
+60,571
| New | +$370K | ﹤0.01% | 1111 |
|
|
2022
Q3 | – | Sell |
-10,325
| Closed | -$114K | – | 1482 |
|
|
2022
Q2 | $114K | Buy |
+10,325
| New | +$114K | ﹤0.01% | 1333 |
|